Innovative microfluidic chip uses only standard lab microscope to spot nano-biomolecules without any fluorescent labels
A novel invention by a team of researchers from the National University of Singapore (NUS) holds promise for a faster and cheaper way to diagnose diseases with high accuracy. Professor Zhang Yong from the Department of Biomedical Engineering at the NUS Faculty of Engineering and his team have developed a tiny microfluidic chip that could effectively detect minute amounts of biomolecules without the need for complex lab equipment.
Diseases diagnostics involves detection and quantification of nano-sized bio-particles such as DNA, proteins, viruses, and exosomes (extracellular vesicles). Typically, detection of biomolecules such as proteins are performed using colorimetric assays or fluorescent labelling with a secondary antibody for detection, and requires complex optical detection equipment such as fluorescent microscopy or spectrophotometry.
One alternative to reduce cost and complexity of disease detection is the adoption of label-free techniques, which are gaining traction in recent times. However, this approach requires precision engineering of nano-features (in a detection chip), complex optical setups, novel nano-probes (such as graphene oxide, carbon nanotubes, and gold nanorods) or additional amplification steps such as aggregation of nanoparticles to achieve sensitive detection of biomarkers.
“Our invention is an example of disruptive diagnostics. This tiny biochip can sensitively detect proteins and nano-sized polymer vesicles with a concentration as low as 10ng/mL (150 pM) and 3.75?g/mL respectively. It also has a very small footprint, weighing only 500 mg and is 6mm³ in size. Detection can be performed using standard laboratory microscopes, making this approach highly attractive for use in point-of-care diagnostics,” explained Prof Zhang.
His team, comprising Dr Kerwin Kwek Zeming and two NUS PhD students Mr Thoriq Salafi and Ms Swati Shikha, published their findings in scientific journal Nature Communications on 28 March 2018.
Novel approach for disease diagnosis
This novel fluorescent label-free approach uses the lateral shifts in the position of the microbead substrate in pillar arrays, for quantifying the biomolecules, based on the change in surface forces and size, without the need of any external equipment. Due to the usage of lateral displacement, the nano-biomolecules can be detected in real-time and the detection is significantly faster in comparison to fluorescent label based detection.
“These techniques can also be extended to many other types of nano-biomolecules, including nucleic acid and virus detection. To complement this chip technology, we are also developing a portable smartphone-based accessory and microfluidic pump to make the whole detection platform portable for outside laboratory disease diagnostics. We hope to further develop this technology for commercialisation,” said Prof Zhang.
The Latest on: Disease detection
[google_news title=”” keyword=”disease detection” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Disease detection
- Expanding rare disease screening in newborns must be a priorityon March 3, 2024 at 3:00 am
I am proud my home state, Minnesota, recently joined the leadership of New York and Ohio by independently opting to add Duchenne to newborn screening requirements. But it is time national officials ...
- Thyroid disease is startlingly common and usually treatableon March 1, 2024 at 1:31 am
Around 12% of the United States population will develop some type of thyroid condition in their lifetime. An estimated 20 million Americans are living with some form of thyroid disease. This is an ...
- Spatial navigation issues in midlife may help predict Alzheimer's disease riskon February 29, 2024 at 2:10 am
Researchers say spatial navigation issues in a person's 40s or 50s could be an early warning sign of Alzheimer's disease risk ...
- Heart disease: Prevention and early detectionon February 28, 2024 at 10:03 am
Every year, more than 875,000 Americans will die from cardiovascular issues. Heart disease and stroke alone are responsible for 1-in-4 deaths among ...
- Researchers develop blood test that can detect Alzheimer's disease earlyon February 27, 2024 at 11:32 am
An international research team led by the Hong Kong University of Science and Technology (HKUST) has reportedly developed a groundbreaking blood test for the early detection of Alzheimer’s disease (AD ...
- Ryght and Lucem Health partner to advance disease detection and treatment with AI technologyon February 27, 2024 at 5:00 am
The collaboration aims to enable Lucem Health to add GenAI to its AI SolutionOps platform and use it to enhance the company's early disease detection and treatment acceleration solutions. Lucem Health ...
- Unlocking the Secrets to Early Alzheimer’s Detectionon February 26, 2024 at 8:01 am
Groundbreaking progress in Alzheimer’s treatment and diagnostics, including biomarkers and blood tests, heralds a new era of early intervention and personalized care in dementia research. Until ...
- Blood test rivals spinal fluid analysis in Alzheimer's detectionon February 22, 2024 at 7:53 pm
A study reveals blood test %p-tau217 matches or surpasses CSF tests in detecting Alzheimer's disease pathology, offering a less invasive, equally accurate alternative for diagnosis across various ...
- Spotlight on early detection of three heart diseases using ECG-AIon February 22, 2024 at 12:25 pm
Early detection of heart disease can make a significant difference in a patient's quality of life and longevity, but a lack of defining symptoms adds complexity. The AI-enabled ECG provides a way to ...
via Bing News